EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols - Test2 - elhamkhani - TriplyDB

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

http://www.wikidata.org/entity/Q24604720

about

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia Diagnosis and subclassification of acute lymphoblastic leukemia Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium Measurable residual disease testing in acute myeloid leukaemia.Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study.Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry Recent advancements of flow cytometry: new applications in hematology and oncology.Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing.Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets.Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood.Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females.Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.Measurement of the T Cell Response to Preerythrocytic Vaccination in Mice.Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia?Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.Immune monitoring in cancer vaccine clinical trials: critical issues of functional flow cytometry-based assays.DNA-directed assembly of antibody-fluorophore conjugates for quantitative multiparametric flow cytometry.Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy.Implementation of highly sophisticated flow cytometry assays in multicenter clinical studies: considerations and guidance.

P2860

Q24604581-D815993C-A6E8-437D-9C21-59CF65E53B94 Q24605023-9BB66833-6789-4E63-9E7C-35FB62C13C1B Q26783577-65A5D842-D1C9-4460-9BA5-FFDE52B91E25 Q26824387-F10FC471-D102-49E7-813F-7B32E2B8AB81 Q26828511-D722F268-64DA-4C60-8126-B01B94D639D9 Q27006773-B601AFAC-2AEB-4A0C-B392-6F494D80313F Q28385156-BEE367C3-13B9-44D6-B9DF-6231DB92B51C Q28601097-F9332B00-D137-4DE0-ADAE-B85B328C52AE Q30234914-6474AEF8-E184-4FA5-85F0-5EE6BDF26808 Q30682927-E728414D-FCE9-48BE-8012-5A5F682B52FB Q30938779-C620B98E-CFE9-4C12-8F87-F98F4ABB0435 Q30952528-1187F4AF-4422-4579-8893-3657262328E2 Q33590468-0D26E6AE-0375-44A1-9B80-D70A5F952226 Q33756582-CF4C14BF-F9D3-4D5D-BAC6-4EAD782AB53A Q33827472-3E3641C3-4012-4D18-864B-F0F5537BFFCA Q35059549-2EB23986-4A87-4CF9-A384-AEDE3A2B8544 Q35146272-A0FCA486-59F0-412E-93C5-82397040069A Q35178180-F3101622-3267-4528-B957-5517E4A3DFB7 Q35672923-AB2318D9-EDE7-4230-9624-668729B08FD0 Q35691393-CA8AC0C8-C915-4D33-A293-3BDF75216319 Q36088901-6FDBC7C2-5617-42C7-BF54-8A3A5E0151B8 Q36371093-142083FF-999D-40A8-940F-8C2B10B5AB4E Q36454220-70284BD2-870B-48B6-826A-50282EBF0806 Q36498366-36801285-12FB-43C7-9A23-B51DAF98092C Q36660666-A51825F6-32D5-4D9A-81A1-9DF37E92E670 Q36950617-DC4F69ED-9B1B-451A-B0AC-D1B035D2C416 Q36981193-4174B055-D315-4352-971B-6B5544EBEC45 Q37101299-786B2B5F-DB97-410C-A500-66DD957EE79A Q37148110-2512995C-B769-48B8-97DE-E4954A8A77C8 Q37269402-FDF75311-71EB-4C66-B567-4C1A09A80FEE Q37385314-A2E41907-A187-4FEA-9C0F-649F48BE4309 Q37624584-BA581D7C-C580-4933-B185-DD9D63F04198 Q37673367-BCACF7D2-44CB-400D-9C6B-222748E717BD Q38096909-D182474C-29BC-48B2-8CA2-1211F6AC0072 Q38123692-9A0194E2-FAFB-4AE2-BCF1-F7645CF125D4 Q38160232-06FDE144-FC65-4CE7-BA71-C722E3124290 Q38310103-4AD97E1D-F104-4D8C-B0F6-743CDDE8AA03 Q38438814-84DE1C4E-695B-49CC-96D9-88B93EB3BEEB Q38452047-F6EB3799-736F-42AF-9EE5-C9CC3D90B368 Q38516622-14CB825C-2B40-47BF-AA82-DF4EC923C5A0

P2860

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

http://www.wikidata.org/entity/Q24604720

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@ast

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@en

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@nl

type

label

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@ast

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@en

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@nl

prefLabel

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@ast

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@en

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@nl

P1433

Q24604720-736A7D24-22F8-40AE-B758-54439B7F015F

P1476

Q24604720-83004118-C5CE-4ADA-A6D2-297EBEF13D77

P2093

Q24604720-0AA96F86-5DCF-4BB2-8A94-694E1BB8B3A1

Q24604720-2B7EBA7D-F068-49D1-A610-50EB5C372BF7

Q24604720-30E8E248-FCC3-4C8E-A3A6-44022A9DF054

Q24604720-3430C135-31A4-4D31-8366-BD49E8E362EB

Q24604720-3D4F3194-3238-48B1-B5BA-BFE0E2E5B998

Q24604720-480BA895-7C87-488E-B36E-37AD5554F2BF

Q24604720-48CD67A9-E78E-492E-B668-47AFFB0C585B

Q24604720-55D5433F-7E3D-4C4E-832A-1B3B0BCCE2E4

Q24604720-6745282E-B930-4CCD-B159-B8AAF51C6FFD

Q24604720-67C1F17E-793E-4F42-B7B9-918463D87A2E

P275

Q24604720-07AECA76-15D0-4194-8B35-6A7D5F4ECC5D

P2860

Q24604720-02307909-A15E-4D79-8C21-574F44C5D7B1

Q24604720-02BF5952-220C-40B6-B370-BF3CA2E28562

Q24604720-076F32E5-3B6E-4B51-A681-D749C29FB25A

Q24604720-07BD1EFE-DCDD-45AE-A0F8-35C84A28C7B6

Q24604720-09ED958C-EBC4-4C9C-984B-FAB0BFD81AEB

Q24604720-0A570030-074B-4CB9-AC14-F3306CF88B8B

Q24604720-11242467-12DC-4078-9864-F77CF9E4455F

Q24604720-16F74DAC-E57C-4ACD-9538-A23D1DB3DDB4

Q24604720-171AFBDA-F2D6-493F-B14E-BE3C3A7D0982

Q24604720-1B91A95E-2C25-4406-9DC4-B1391399C584

P2888

Q24604720-18F45A19-0744-4513-B1A1-40FEA8F13A1B

P304

Q24604720-8DEDE8FC-7101-4386-BB6B-096952215C7D

P31

Q24604720-47FCF6B2-C599-4357-B149-20492005683A

Q24604720-93C3EE1F-6930-4C17-B64D-19DD49EFD765

P3181

Q24604720-D4197B9D-2D4F-4C34-9E21-C8B7D3E9A683

P356

Q24604720-07BD8C1D-32F7-4A94-BFF2-47EEB73B3FF2

P407

Q24604720-06EC272C-3584-4AE3-9406-AE4E036F164C

P433

Q24604720-C893AAC2-2159-450D-B8AB-16160698B719

P478

Q24604720-4C97C2D8-BD6E-4D98-9468-6EBF49E2C141

P5008

Q24604720-19E6C8C7-34F2-49A2-A28C-BCCD1D7938A5

P577

Q24604720-B174FA28-6CAF-463A-926F-D649DF1E3C83

Q24604720-E62F4A3E-3B01-4788-AE4D-8F3C78ED129C

P5875

Q24604720-052805B9-8BFD-47A8-B3D3-B811C59E1B5A

P6179

Q24604720-82C6CA3F-2991-47C6-BC62-12AF04403D8D

P698

Q24604720-AE1E3ED1-94E6-49D0-A26A-E2FA4DC523AE

P921

Q24604720-1C258DC6-B1F1-424D-B3E6-AE1FBCC9335D

Q24604720-602F8AB3-B563-41C8-B515-FCC1F2AC6464

Q24604720-77a6a5ed-4f7c-4716-716f-cbc051fd2735

Q24604720-8099E494-07D7-4859-A768-B808ABA628CA

Q24604720-EC074088-C126-4271-806E-4E2DFC6305B8

Q24604720-c6bab822-4855-bb0b-40cb-df3f8757e110

P932

Q24604720-3DEF6D14-C437-40A5-8830-60EE22B2BB0F

P3181

P356

P1433

P1476

EuroFlow standardization of fl ...... nd immunophenotyping protocols

@en

P2093

A Mendonça

http://www.w3.org/2001/XMLSchema#string

A Orfao

http://www.w3.org/2001/XMLSchema#string

E Mejstrikova

http://www.w3.org/2001/XMLSchema#string

J Almeida

http://www.w3.org/2001/XMLSchema#string

J Flores-Montero

http://www.w3.org/2001/XMLSchema#string

J G te Marvelde

http://www.w3.org/2001/XMLSchema#string

J J M van Dongen

http://www.w3.org/2001/XMLSchema#string

J J Pérez

http://www.w3.org/2001/XMLSchema#string

L Lhermitte

http://www.w3.org/2001/XMLSchema#string

L Sedek

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping

Fluorescent proteins from nonbioluminescent Anthozoa species

New approaches to fluorescence compensation and visualization of FACS data.

A practical approach to multicolor flow cytometry for immunophenotyping.

A new automated flow cytometry data analysis approach for the diagnostic screening of neoplastic B-cell disorders in peripheral blood samples with absolute lymphocytosis.

Generation of flow cytometry data files with a potentially infinite number of dimensions.

Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.

Setting up and calibration of a flow cytometer for multicolor immunophenotyping.

Violet laser diodes in flow cytometry: an update.

P2888

P304

1986-2010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1194568

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/LEU.2012.122

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230797414

http://www.w3.org/2001/XMLSchema#string

P6179

1045954846

http://www.w3.org/2001/XMLSchema#string

P698

22948490

http://www.w3.org/2001/XMLSchema#string

P921

immunologic tests

biomedical investigative technique

hematologic neoplasm

Immunophenotyping

P932

3437409

http://www.w3.org/2001/XMLSchema#string